Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)
Clinical trial NCT00109538 · TERMINATED
Trial details
- NCT number
- NCT00109538
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2008-08-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.